Discover Insights

Add Your Heading Text Here

A Fascinating Asset Class: A Conversation with Seth Dancy about Syndicated Loans

Legalweek: What can you reasonably expect out of ChatGPT?

Legalweek: What can you reasonably expect out of ChatGPT?

Date: April 3, 2023  

Legalweek 2023 kicked off with a packed, “standing room only” panel discussion featuring Aaron Crews, UnitedLex Chief Product and Innovation Officer. Reshaping the Legal Profession: Thriving in the Age of Generative AI & ChatGPT touched on how generative AI can be applied to legal, including the notable ChatGPT and its impact on the industry’s future. 

As a panel participant, Crews compared the heavily-hyped technology as less of a do-it-all tool and more of a “moderately bright, but very lazy first-year associate.” 

Crews noted that while many legaltech types have high hopes for generative AI use in law, including himself, at its core the technology isn’t that revolutionary. 

“Generative AI is fancy marketing-speak for a machine that anticipates where you want to go next,” he said, adding that while there may be high expectations of a tool named artificial intelligence, in reality “it’s not intelligent.” 

Read the full article by Zach Warren, Manager for Enterprise Content for Technology & Innovation, Thomson Reuters Institute, here.

Related Content

Beyond the Lookalike: How Dupes are Testing the Boundaries of IP Law 

As dupe culture rises, luxury brands face new IP battles—where’s the line between inspiration and infringement?

High Impact Legal Operations: How to Build a Legal Operations Center of Excellence

As budgets tighten, new technologies emerge, and internal teams are forced to do more with less, it may be time to reimagine your legal operations strategy.

Booster Shot: How Legal Departments are Driving Value in Life Sciences

Explore how legal teams are protecting innovation, managing risk, and creating value—while keeping costs under control.

Medtech Patent Battles: Key Litigation Trends and How NPEs are Shaping the Landscape 

Acritical analysis of the evolving patent litigation landscape in Medtech, highlighting several trends shaping our industry.